199 related articles for article (PubMed ID: 33492639)
1. A novel ligand of the translationally controlled tumor protein (TCTP) identified by virtual drug screening for cancer differentiation therapy.
Fischer N; Seo EJ; Abdelfatah S; Fleischer E; Klinger A; Efferth T
Invest New Drugs; 2021 Aug; 39(4):914-927. PubMed ID: 33492639
[TBL] [Abstract][Full Text] [Related]
2. AMG900 as novel inhibitor of the translationally controlled tumor protein.
Fischer N; Seo EJ; Klinger A; Fleischer E; Efferth T
Chem Biol Interact; 2021 Jan; 334():109349. PubMed ID: 33259807
[TBL] [Abstract][Full Text] [Related]
3. Interaction of antihistaminic drugs with human translationally controlled tumor protein (TCTP) as novel approach for differentiation therapy.
Seo EJ; Efferth T
Oncotarget; 2016 Mar; 7(13):16818-39. PubMed ID: 26921194
[TBL] [Abstract][Full Text] [Related]
4. Peptide aptamer identified by molecular docking targeting translationally controlled tumor protein in leukemia cells.
Kadioglu O; Efferth T
Invest New Drugs; 2016 Aug; 34(4):515-21. PubMed ID: 26972431
[TBL] [Abstract][Full Text] [Related]
5. Revisiting the Molecular Interactions between the Tumor Protein TCTP and the Drugs Sertraline/Thioridazine.
Malard F; Jacquet E; Nhiri N; Sizun C; Chabrier A; Messaoudi S; Dejeu J; Betzi S; Zhang X; Thureau A; Lescop E
ChemMedChem; 2022 Jan; 17(1):e202100528. PubMed ID: 34472703
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Specific Translational Machinery via TCTP-EF1A2 Interaction Regulating NF1-associated Tumor Growth by Affinity Purification and Data-independent Mass Spectrometry Acquisition (AP-DIA).
Kobayashi D; Tokuda T; Sato K; Okanishi H; Nagayama M; Hirayama-Kurogi M; Ohtsuki S; Araki N
Mol Cell Proteomics; 2019 Feb; 18(2):245-262. PubMed ID: 30381327
[TBL] [Abstract][Full Text] [Related]
7. Selection of a GPER1 Ligand via Ligand-based Virtual Screening Coupled to Molecular Dynamics Simulations and Its Anti-proliferative Effects on Breast Cancer Cells.
Martínez-Muñoz A; Prestegui-Martel B; Méndez-Luna D; Fragoso-Vázquez MJ; García-Sánchez JR; Bello M; Martínez-Archundia M; Chávez-Blanco A; Dueñas-González A; Mendoza-Lujambio I; Trujillo-Ferrara J; Correa-Basurto J
Anticancer Agents Med Chem; 2018; 18(11):1629-1638. PubMed ID: 29745344
[TBL] [Abstract][Full Text] [Related]
8. Selective CDK4/6 inhibition of novel 1,2,3-triazole tethered acridinedione derivatives induces G1/S cell cycle transition arrest via Rb phosphorylation blockade in breast cancer models.
Praveenkumar E; Gurrapu N; Kolluri PK; Shivaraj ; Subhashini NJP; Dokala A
Bioorg Chem; 2021 Nov; 116():105377. PubMed ID: 34670329
[TBL] [Abstract][Full Text] [Related]
9. Role of TCTP for Cellular Differentiation and Cancer Therapy.
Seo EJ; Fischer N; Efferth T
Results Probl Cell Differ; 2017; 64():263-281. PubMed ID: 29149414
[TBL] [Abstract][Full Text] [Related]
10. RNA interference‑mediated knockdown of translationally controlled tumor protein induces apoptosis, and inhibits growth and invasion in glioma cells.
Jin H; Zhang X; Su J; Teng Y; Ren H; Yang L
Mol Med Rep; 2015 Nov; 12(5):6617-25. PubMed ID: 26328748
[TBL] [Abstract][Full Text] [Related]
11. AI-based Virtual Screening of Traditional Chinese Medicine and the Discovery of Novel Inhibitors of TCTP.
Bai J; Ni Y; Zhang Y; Wan J; Liang L; Qiao H; Zhu Y; Zhao Q; Li H
Curr Comput Aided Drug Des; 2024 Jan; ():. PubMed ID: 38310576
[TBL] [Abstract][Full Text] [Related]
12. The anti-malarial drug artesunate causes cell cycle arrest and apoptosis of triple-negative MDA-MB-468 and HER2-enriched SK-BR-3 breast cancer cells.
Greenshields AL; Fernando W; Hoskin DW
Exp Mol Pathol; 2019 Apr; 107():10-22. PubMed ID: 30660598
[TBL] [Abstract][Full Text] [Related]
13. Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights.
Sabt A; Eldehna WM; Al-Warhi T; Alotaibi OJ; Elaasser MM; Suliman H; Abdel-Aziz HA
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1616-1630. PubMed ID: 32781872
[TBL] [Abstract][Full Text] [Related]
14. Combination of dihydroartemisinin and resveratrol effectively inhibits cancer cell migration
Gao J; Ma F; Wang X; Li G
Food Funct; 2020 Nov; 11(11):9573-9584. PubMed ID: 33150340
[TBL] [Abstract][Full Text] [Related]
15. Structure-based discovery of the first allosteric inhibitors of cyclin-dependent kinase 2.
Rastelli G; Anighoro A; Chripkova M; Carrassa L; Broggini M
Cell Cycle; 2014; 13(14):2296-305. PubMed ID: 24911186
[TBL] [Abstract][Full Text] [Related]
16. New castanospermine glycoside analogues inhibit breast cancer cell proliferation and induce apoptosis without affecting normal cells.
Allan G; Ouadid-Ahidouch H; Sanchez-Fernandez EM; Risquez-Cuadro R; Fernandez JM; Ortiz-Mellet C; Ahidouch A
PLoS One; 2013; 8(10):e76411. PubMed ID: 24124558
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Biological Evaluation and In Silico Studies of Certain Oxindole-Indole Conjugates as Anticancer CDK Inhibitors.
Al-Warhi T; El Kerdawy AM; Aljaeed N; Ismael OE; Ayyad RR; Eldehna WM; Abdel-Aziz HA; Al-Ansary GH
Molecules; 2020 Apr; 25(9):. PubMed ID: 32349307
[TBL] [Abstract][Full Text] [Related]
18. A computer-aided drug design approach to discover tumour suppressor p53 protein activators for colorectal cancer therapy.
Patrício RPS; Videira PA; Pereira F
Bioorg Med Chem; 2022 Jan; 53():116530. PubMed ID: 34861473
[TBL] [Abstract][Full Text] [Related]
19. The anticancer activity of the substituted pyridone-annelated isoindigo (5'-Cl) involves G0/G1 cell cycle arrest and inactivation of CDKs in the promyelocytic leukemia cell line HL-60.
Saleh AM; Aljada A; El-Abadelah MM; Taha MO; Sabri SS; Zahra JA; Aziz MA
Cell Physiol Biochem; 2015; 35(5):1943-57. PubMed ID: 25870953
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and In Vitro Evaluation of Tetrahydroquinoline Derivatives as Antiproliferative Compounds of Breast Cancer via Targeting the GPER.
Zacarías-Lara OJ; Méndez-Luna D; Martínez-Ruíz G; García-Sanchéz JR; Fragoso-Vázquez MJ; Bello M; Becerra-Martínez E; García-Vázquez JB; Correa-Basurto J
Anticancer Agents Med Chem; 2019; 19(6):760-771. PubMed ID: 30451119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
